Same Indication

Ipilimumab vs Pantoprazole

Ipilimumab vs Pantoprazole: Overview

This comparison examines the pharmacological differences between Ipilimumab and Pantoprazole.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pantoprazole: Proton pump inhibitor.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Pantoprazole β€” 1 hour.

Chemical Properties

Molecular Formula: Pantoprazole β€” C16H15F2N3O4S.

Molecular Weight: Pantoprazole β€” 383.3710 g/mol.

Type: Ipilimumab β€” Antibody; Pantoprazole β€” Small molecule.